California-based Capstan Medical, maker of robotic-enabled tools for heart valve disease, closed an oversubscribed $110 million Series C round led by Eclipse.
Existing investors Intuitive Ventures, Yu Galaxy, and new investor Gideon Strategic Partners, participated in the round.
WHAT IT DOES
The company offers surgical robotics with catheter-based technology and implants to repair and replace...
Update: This story has been updated to include additional quotes from the study's researchers.
Heart disease patients visiting mobile health clinics outfitted with pocket-sized, smartphone-connected ECGs and other point-of-care medical devices are more quickly referred for therapy, and less frequently experience hospitalization or death.
According to a recent study, published in the Journal of...
Ambre Health CTO and co-founder Brek Wilkins
One of the biggest complaints about healthcare, one of the biggest pain points that digital technology promises to solve, is that data sits in silos, so that even if a piece of data could help a patient, it might not be in the hands of the doctor who needs to see it.
Ambre Health, a recently formed startup out of Oklahoma State University (OSU),...
Pharmaceutical giant Novartis announced that would invest $24M in upfront cash and equity as part of an exclusive worldwide agreement for the pharma company to license Proteus Biomedical's sensing technology for organ transplantation. (That must be the kind of exclusive deal Novartis had in mind when the two companies announced their collaboration on a pilot last year.)
As part of the deal,...
